DYAX



Trademark Coverage

No Class Specified

pharmaceutical compound for use in the treatment and/or prevention of inflammation in genetic, cardiovascular, pulmonary, oncologic, and rheumatoid diseases and complications of surgical or interventional procedures

Owner

Dyax Corp

Business in Cambridge, MA

Owns 7 trademarks

Timeline
  • Dec 06
    2013
    Cancelled SEC 8 (10 Yr)/Expired Section 9
  • Oct 23
    2011
    TEAS Change Of Correspondence Received
  • May 08
    2009
    Registered SEC 8 (6 Yr) Accepted & SEC 15 ACK
  • Apr 28
    2009
    Assigned To Paralegal
  • Apr 27
    2009
    TEAS Section 8 & 15 Received
  • Jan 22
    2008
    Case File In TICRS
  • Apr 29
    2003
    Registered Principal Register
  • Feb 04
    2003
    Published For Opposition
  • Jan 15
    2003
    Notice Of Publication
  • Dec 03
    2002
    Approved For PUB Principal Register
  • Dec 03
    2002
    Use Amendment Accepted
  • Nov 29
    2002
    Amendment To Use Processing Complete
  • Nov 01
    2002
    Use Amendment Filed
  • Nov 01
    2002
    Correspondence Received In Law Office
  • Nov 01
    2002
    Paper Received
  • Oct 17
    2002
    Assigned To Examiner
  • Dec 28
    2001
    Correspondence Received In Law Office
  • Jan 28
    2002
    Letter Of Suspension Mailed
  • Jan 28
    2002
    Previous Allowance Count Withdrawn
  • Jan 23
    2002
    Notice Of Allowance Cancelled
  • Sep 04
    2001
    NOA Mailed SOU Required From Applicant
  • Jun 12
    2001
    Published For Opposition
  • May 30
    2001
    Notice Of Publication
  • Feb 08
    2001
    Approved For PUB Principal Register
  • Feb 08
    2001
    Assigned To Examiner
  • Jan 23
    2001
    Assigned To Examiner